Clinical trials
Active, not recruiting Biliary Tract Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 6 |
| Eli Lilly and Company | 2 |
| Amgen | 1 |
| Compass Therapeutics | 1 |
| Fujifilm Pharmaceuticals U.S.A., Inc. | 1 |
| Georgetown University | 1 |
| Massachusetts General Hospital | 1 |
| Seagen, a wholly owned subsidiary of Pfizer | 1 |
| Servier Bio-Innovation LLC | 1 |
| SystImmune Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biliary Tract Neoplasms | 17 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Cholangiocarcinoma | 3 |
| Colorectal Neoplasms | 3 |
| Stomach Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Carcinoma, Hepatocellular | 2 |
| Endometrial Neoplasms | 2 |
| Gallbladder Neoplasms | 2 |
| Ovarian Neoplasms | 2 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.